Veru Inc (VERU)
1.32
-0.05
(-3.65%)
USD |
NASDAQ |
May 17, 16:00
1.35
+0.03
(+2.27%)
Pre-Market: 20:00
Veru Price to Book Value: 4.274 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 4.274 |
| May 16, 2024 | 4.436 |
| May 15, 2024 | 4.760 |
| May 14, 2024 | 4.760 |
| May 13, 2024 | 4.306 |
| May 10, 2024 | 4.306 |
| May 09, 2024 | 4.436 |
| May 08, 2024 | 4.630 |
| May 07, 2024 | 5.278 |
| May 06, 2024 | 5.310 |
| May 03, 2024 | 5.278 |
| May 02, 2024 | 5.31 |
| May 01, 2024 | 4.824 |
| April 30, 2024 | 4.371 |
| April 29, 2024 | 4.047 |
| April 26, 2024 | 4.112 |
| April 25, 2024 | 3.918 |
| April 24, 2024 | 4.274 |
| April 23, 2024 | 4.128 |
| April 22, 2024 | 4.112 |
| April 19, 2024 | 4.242 |
| April 18, 2024 | 4.598 |
| April 17, 2024 | 3.756 |
| April 16, 2024 | 4.064 |
| April 15, 2024 | 4.954 |
| Date | Value |
|---|---|
| April 12, 2024 | 4.922 |
| April 11, 2024 | 5.796 |
| April 10, 2024 | 4.015 |
| April 09, 2024 | 3.788 |
| April 08, 2024 | 3.335 |
| April 05, 2024 | 2.995 |
| April 04, 2024 | 2.687 |
| April 03, 2024 | 2.684 |
| April 02, 2024 | 2.507 |
| April 01, 2024 | 2.461 |
| March 31, 2024 | |
| March 28, 2024 | 1.986 |
| March 27, 2024 | 1.834 |
| March 26, 2024 | 1.730 |
| March 25, 2024 | 1.728 |
| March 22, 2024 | 1.589 |
| March 21, 2024 | 1.628 |
| March 20, 2024 | 1.674 |
| March 19, 2024 | 1.706 |
| March 18, 2024 | 1.610 |
| March 15, 2024 | 1.645 |
| March 14, 2024 | 1.702 |
| March 13, 2024 | 1.818 |
| March 12, 2024 | 1.79 |
| March 11, 2024 | 1.867 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.050
Minimum
Jan 19 2024
30.65
Maximum
Feb 12 2021
6.170
Average
4.735
Median
Apr 21 2021
Price to Book Value Benchmarks
| EyePoint Pharmaceuticals Inc | 2.467 |
| INVO Bioscience Inc | -- |
| Bio-Path Holdings Inc | 3.294 |
| Aileron Therapeutics Inc | 11.57 |
| ProKidney Corp | -- |
Price to Book Value Related Metrics
| PS Ratio | 10.42 |
| Price | 1.32 |
| Earnings Yield | -25.76% |
| Market Cap | 193.23M |